Are pharmaceutical manufacturers struggling with release delays or regulatory flagged batches? This challenge often arises when quality assurance roles and responsibilities are blurred or undefined. Ambiguity fosters non-compliance, inspection findings and costly rework. By clearly delineating the responsibilities of the QP and QA Manager, your organization can enforce robust oversight, reduce errors, and restore trust in every batch release.

What makes the role of a qualified person (QP) essential in pharmaceutical quality assurance?

The Qualified Person (QP) is a cornerstone of EU pharmaceutical governance, because quality assurance roles and responsibilities at the highest level depend on having a legally accountable individual. In the EU regulatory framework, under Directive 2001/83/EC, Article 51, and EudraLex Vol. 4 Annex 16, no batch of a medicinal product can be released unless the QP certifies that it has been manufactured and checked in compliance with Good Manufacturing Practice (GMP) and the terms of the marketing authorization.

In many cases, as part of our GMP consulting services, we help clients design systems so that the QP can rely on underlying quality systems with confidence. The QP must ensure the integrity of documentation, review deviations, assess supplier audits, confirm validation, and address out-of-specification issues — all within a strong pharmaceutical quality system.

Thus, within quality assurance roles and responsibilities, the QP’s role is not simply a “sign-off person” but the ultimate guardian of compliance and patient safety. The QP integrates inputs from manufacturing, quality control, supply chain, and compliance to make an informed certification decision. If a batch is released incorrectly, the QP bears both professional and legal risk.

How do QP and QA manager responsibilities differ in daily manufacturing practice?

When comparing quality assurance roles and responsibilities in a real manufacturing environment, the QP and QA Manager occupy distinct but complementary functions. The QA Manager generally designs, implements, and maintains the Quality Management System (QMS) that assures ongoing compliance with EudraLex Vol. 4 Chapters 1 and 2 as well as FDA 21 CFR Parts 210–211 Subpart B. They coordinate audits, manage deviations, drive training, oversee change control, and liaise across departments to maintain compliance.

The QP, however, bears personal legal responsibility for certifying each batch prior to release. The QP does not (necessarily) do all daily checks but must rely on and assess the output of the QA Manager’s system. The QP may delegate certain tasks, but not the ultimate decision to release the batch.

In our own operations at Billev Pharma East, we ensure the roles are structured so the QA Manager can optimize operational quality processes, while the QP remains independent and reviews system outputs objectively before certification. This separation of duties is essential to maintain credibility with regulators and to uphold quality assurance roles and responsibilities across levels.

On a day-to-day level: the QA Manager will monitor process metrics, follow up on nonconformities, propose CAPA, manage audits and training, whereas the QP’s daily input may involve reviewing critical deviations, inbound supplier audit reports, trend data, and the final batch documentation before sign-off.

Thus, in practice, where the QA Manager ensures the smooth functioning of the QA system, the QP ensures that system outputs are trustworthy and fit for formal release. The clarity in quality assurance roles and responsibilities between them prevents conflicts of interest and reinforces compliance integrity.

What are the core quality assurance roles and responsibilities that overlap between QP and QA manager?

Even though QPs and QA Managers have distinct accountabilities, there is overlap in quality assurance roles and responsibilities where collaboration is essential. For example:

• Deviation and CAPA oversight: both must engage in reviewing root cause investigations, assessing risk, and approving corrective/preventive actions. The QA Manager often drives the CAPA process; the QP must review conclusions before batch release.
• Audit programmes: the QA Manager typically organizes and executes internal and supplier audits; the QP may review audit findings and ensure corrective actions are closed satisfactorily.
• Change control and review of process validation: QA Manager supervises change control, ensuring risk assessments, validation requalification, and documentation; the QP evaluates impact on compliance.
• Document review and record integrity: QA Manager ensures that SOPs, batch records, validation protocols, and quality systems are maintained; the QP must be confident that records are complete, traceable, and accurate before certification.
• Supplier qualification and oversight: QA Manager manages supplier audits, performance metrics, requalification; QP confirms supplier reliability for release decisions.
• Training: QA Manager designs and monitors training programs; the QP may periodically assess whether personnel competence meets needs, especially for tasks relevant to release decisions.

These overlapping quality assurance roles and responsibilities demand coordinated communication and transparent hand-offs to prevent misinterpretation and regulatory gaps.

Which quality assurance roles and responsibilities are shared between QP and QA manager?

Even though the QP and QA Manager have distinct ultimate accountabilities, there are important areas where their quality assurance roles and responsibilities overlap and require tight coordination. Below is a concise comparison:

These shared functions underpin the fact that quality assurance roles and responsibilities are not isolated silos but part of an integrated system. Successful implementation requires clear communication, mutual checks, and defined boundaries on who initiates, executes, or reviews each activity.

How does regulatory compliance define the boundaries between QP and QA functions?

Regulatory frameworks—especially the EU’s EudraLex Volume 4, Annex 16 —explicitly delineate the responsibilities of a QP, setting the legal line between QP and QA roles. Annex 16 mandates that a QP must ensure that each batch has been manufactured, tested, and documented in full compliance with GMP, the marketing authorization, and national law. The regulation grants the QP the power and obligation to withhold certification if doubts remain.

Meanwhile, QA functions (via the QA Manager and QA systems) support compliance by implementing the quality management system (QMS), conducting audits, controlling change/processes, managing deviations, and maintaining documentation. But QA does not bear the same personal legal liability for batch release. The regulatory boundary is also clear in delegation: certain tasks may be delegated (e.g. parts of quality review, data collection), but the QP retains final responsibility and must be able to justify decisions. Thus, regulatory compliance enforces a firewall of independence: QA executes and manages the processes, QP independently reviews and certifies. This separation is fundamental to maintain public trust and regulatory oversight.

In sum, regulations codify that while quality assurance roles and responsibilities include managing and ensuring system robustness, only the QP can legally certify product release — making regulatory compliance itself a guiding principle in their division of duties.

Can a QA manager perform QP duties, and under what conditions?

A common question is whether the QA Manager can double as the QP. The simple answer is: in certain organizations and jurisdictions it might be permitted, but substantial risks and constraints apply. First, the QP role carries legal liability that goes beyond managerial oversight. The QP must exercise independent judgment and must not be unduly influenced by commercial or operational pressures — something a QA Manager might face. Because of this, regulators often favour institutional separation.

Second, regulations like EU Annex 16 permit delegation of certain tasks, but the QP cannot entirely hand off decision authority. Even if the QA Manager holds both titles, they must maintain objective independence when performing QP functions.

Third, any arrangement where a QA Manager also acts as QP should be documented explicitly, with risk assessments, clear segregation in workflows, and safeguards (e.g. second reviews, independent checks). Companies must demonstrate through audits that no conflict of interest exists.

If the QA Manager is also nominally the QP, the system must still meet all quality assurance roles and responsibilities expected of both functions separately. Governance documents, role definitions, and internal processes must keep the decision to certify batches isolated from operational influence.

In many mature organizations, and especially in highly regulated markets, it is safer and more defensible to maintain separate persons or at least define sufficiently segregated responsibilities — to ensure both compliance and the integrity of the certification decision.

Can QA manager also assume quality assurance roles and responsibilities of a QP — under what safeguards?

If a QA Manager also assumes QP tasks, they must ensure that the quality assurance roles and responsibilities of certification—particularly independence and legal accountability—are strictly protected via safeguards:

• Independent decision-making: When acting in QP mode, the individual must be insulated from operational pressures and managerial influence at that time.
• Dual workflow documentation: Clear distinction must exist in formal procedures when functioning as QA Manager vs. QP, with separate logs, signoffs, and role declarations.
• Second review or peer oversight: Introduce a check by another qualified professional to review key release decisions, especially for borderline or critical batches.
• Documented risk assessment and governance: The dual role must be justified in governance documents and risk assessments, demonstrating that potential conflicts have been mitigated.
• Regulatory readiness evidence: The organization must be able to show during audits/inspections that certification decisions were made independently and properly, respecting all QP duties including refusal if doubt remains.

When properly safeguarded, the individual must still fulfil all quality assurance roles and responsibilities that a standalone QP would — including batch certification, deviation review, supplier oversight, and ensuring full compliance with GMP and regulatory expectations.

How do QP decisions impact overall quality assurance performance and product release?

The QP’s decisions have cascading influence across all levels of the quality assurance roles and responsibilities framework. When a QP withholds certification on a batch (due to unresolved deviations, insufficient audit evidence, or data integrity concerns), that triggers investigations, holds, and possibly recall or rework actions. This outcome enforces rigor in upstream systems.

Because the QP reviews the aggregate evidence from manufacturing, quality control, validation, deviation systems, supplier audits, and trend analyses, their decision effectively validates (or rejects) the quality assurance system’s outputs. A consistent record of withheld batches forces QA systems to self-correct and prevents repeat failures.

Conversely, a QP decision to release a questionable batch may introduce product risk or regulatory noncompliance; when that happens, the QA Manager’s processes come under scrutiny. Over time, the QP’s decisions define the tone of rigor — whether “things slip through” or every anomaly is rigorously assessed. Moreover, QP decisions impact performance metrics: batch release timelines, rejection rates, cost of recourse actions, inspection outcomes, and overall supply reliability. A vigilant QP helps maintain the standard of trust with regulators, customers, and end users.

In effect, QP decisions act as a quality gate at the last point. They shape the entire culture of accountability, pushing upstream owners (manufacturing, QC, QA) to strengthen their processes. That is why clear delineation and respect of quality assurance roles and responsibilities is crucial — the QP must have full access to data, independence of judgment, and the authority to refuse release.

Why is clear separation of quality assurance roles and responsibilities critical for GMP compliance?

A clear separation of quality assurance roles and responsibilities is vital to maintain system integrity, prevent conflicts of interest, and satisfy regulatory expectations. Without such separation, the risk is that operational pressure, commercial incentives, or organizational bias might influence release decisions — undermining the confidence regulators place in the QP’s independence.

Regulators, particularly in the EU, expect that the QP remains autonomous from day-to-day production and that QA systems deliver reliable outputs. If the QP were fully embedded within production oversight, their ability to act objectively could be questioned.

Separation ensures checks and balances: the QA Manager handles process execution, audits, deviation management, and system operation, while the QP performs independent review and batch certification. This division reduces the chance of compromised decision making.

From a compliance perspective, auditors often look for evidence that the QP had access to unfiltered data, had authority to reject batches, and was not pressured by production goals. A blurred boundary can lead to critical observations in inspections or even regulatory sanctions.

Finally, the separation helps enforce rigor in quality assurance roles and responsibilities at every level — people know which tasks belong to operational QA and which to certification oversight. This clarity aids training, accountability, governance, and auditability.

Read also:

• What are the best GMP solutions: Custom or Off-the-Shelf?
• How do EU requirements shape qualified person qualification for outsourced QP release?

Sources: 1 – EU GMP Annex 16: Certification by a Qualified Person and Batch Release, 2 – The Responsibilities of the Qualified Person according to EU Annex 16. (2023, September 25). GMP Compliance Adviser., 3 – A Review on Quality Assurance and Quality Management System in Pharmaceutical Industry. (n.d.). International Journal of Pharmaceutical Sciences.